Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

GSK’s ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms

The future of ViiV Healthcare’s HIV business is injectable. By 2026, the majority-GlaxoSmithKline-owned joint venture expects long-acting regimens to generate around £2 billion ($2.65 billion) in sales. And by 2031, it estimates that 90% of its business will be in that same long-acting market, executives said Monday on a call with investors.  ViiV expects injectables to […]

Aspen closes in on Africa license for Johnson & Johnson’s COVID-19 vaccine

One of Johnson & Johnson’s long-held pandemic manufacturing partners just made headway in its quest to license the company’s shot in Africa. Aspen Pharmacare on Tuesday inked a non-binding term sheet with two of J&J’s Janssen subsidiaries, the company said in an emailed statement. If the agreement yields a definitive deal, Aspen will become the […]

COVID-19 tracker: An FDA advisory group will discuss Merck antiviral; Companies test vaccines against new variant

Companies are testing their COVID-19 vaccines against the new variant, omicron. An FDA advisory committee will meet tomorrow to discuss its recommendation of Merck’s COVID-19 antiviral. The worldwide case count stood at more than 261.98 million Monday afternoon, with more than 5.2 million reported deaths, according to Johns Hopkins University’s COVID-19 dashboard. Please read below for […]

Pfizer boosts Paxlovid manufacturing capacity as Merck’s rival COVID pill hits surprise efficacy setback

The efficacy data for Pfizer’s oral COVID-19 drug now look so appealing that the Big Pharma company is boosting manufacturing capacity even before an expected emergency use authorization from the FDA. Pfizer now expects to make 80 million courses of COVID drug Paxlovid by the end of 2022, Pfizer CEO Albert Bourla told CNBC during […]

Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron

After Amgen earlier this year suffered a third consecutive loss in its high-profile PCSK9 patent feud with Sanofi and Regeneron, the company faced two choices: appeal further or drop the issue.  Not content to play sitting duck, Amgen has asked the Supreme Court to step in and review the case. Amgen wants the U.S. Supreme […]

Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China’s latest cost squeeze

On the centennial of the discovery of insulin, China decided a round of price cuts on the diabetes therapy is due. As a result, foreign companies Novo Nordisk, Sanofi and Eli Lilly are taking a beating in the key market. Forty-two insulin products from companies foreign and domestic took an average 48% discount to win […]

Former Insys execs ordered to pay $48.3 million in restitution in Subsys opioid trial

Insys Therapeutics’ former top brass owes a collective $48.3 million in restitution for its role in the U.S. opioid crisis, a federal court in Boston ruled this month.  Insys founder John Kapoor will pay the bulk of that amount, while contributions from three former Insys executives will be capped at $5 million apiece, the United […]

Acadia gives voice to personal stories about Parkinson’s psychosis in new bilingual campaign

Hallucinations and delusions are some of the least talked-about symptoms of Parkinson’s disease—and, for many, the scariest.  Drugmaker Acadia Pharmaceuticals is trying to change that by encouraging patients to open up about their experiences. And it is turning to storytelling experts at StoryCorps to help. Acadia enlisted the oral history nonprofit, featured on NPR, for […]

Pfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine

Pfizer and other drugmakers go to great lengths to protect their proprietary information. When it comes to the world’s best-selling pharmaceutical product, the company’s BioNTech-partnered COVID-19 vaccine, Pfizer’s defense of trade secrets carries even more weight. That’s why the company is working to get a handle on information allegedly stolen by a “soon-to-be former employee.” […]

Bushu expects to double the volume of Amgen drugs it makes under new Asia CMO pact

With operations locked up in Japan, Bushu Pharmaceuticals is expanding its contract manufacturing pact with Amgen across Asia. Bushu will now offer Amgen its “Gateway to Asia” services in four countries across the region including massive markets in mainland China, Taiwan and South Korea, the companies said in a joint press release Wednesday. Under the […]

Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January

When Sun Pharma acquired troubled Ranbaxy in 2014 for $4 billion, the India generics giant knew it was inheriting some major compliance problems. At the time, four of Ranbaxy’s five plants were sidelined by the FDA. Six years later, the Ranbaxy headache persists for Sun as Boston federal judge Nathaniel Gorton denied an attempt by Sun […]

After Biden admin failed to submit FDA chief paperwork on time, hopes for a speedy confirmation vote likely dashed: report

The Biden administration’s hopes of getting a new FDA commissioner next month have likely been dashed, all because the government forgot to turn in its homework, Politico reports. The administration had planned to hustle the nomination for Robert Califf, M.D., through the Senate in December, according to the publication. Problem is, the government failed to […]